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2000) (9,10). Of the two case-patients,
one soldier did not leave NDjamena
during his 3-month tour of duty,
whereas the other had been in contact
with livestock in a flooded area before
onset of symptoms. Contamination
may have occurred through infected
animals or mosquitoes, although
sheep living in the area did not show
any sign of disease (i.e., spontaneous
abortions, deaths). The two cases we
describe were self-limiting; however,
deaths from this illness have been
reported in nonepidemic settings in
Central African Republic (11). Our
data emphasize that healthcare
providers should systematically con-
sider Rift Valley fever as a diagnosis
for febrile syndromes in persons
returning from Africa, even in nonepi-
demic settings (12).
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Corynebacterium
ulcerans Diphtheria
in Japan 
To the Editor:  Corynebacterium
ulcerans causes a zoonotic infection
similar to diphtheria, which is caused
by  C. diphtheriae. Studies indicate
that signs and symptoms of a diphthe-
ria-like illness caused by C. ulcerans
are milder than those caused by C.
diphtheriae. However, some strains of
C. ulcerans produce potent diphtheria
toxin and may cause severe symptoms
similar to those caused by C. diphthe-
riae (1). We report a case of a diphthe-
ria-like illness caused by C. ulcerans
infection.
A previously healthy 52-year-old
woman first noticed hoarseness
approximately 3 days before admis-
sion to the hospital. On February 16,
2001, severe dyspnea and fever devel-
oped, and the patient was referred to
the emergency room of the Asahi
General Hospital by her private prac-
titioner. Physical examination indicat-
ed a large stridor, which could be
heard without using a stethoscope.
Cyanosis was not observed. The
endoscopic examination showed a
thick white coat covering the
nasopharynx and laryngeal vestibu-
lum, and subglottic constriction was
also observed. A chest x-ray showed
diffuse infiltrates in both lungs.
Pertinent laboratory findings on
admission included leukocyte count
of 16.8 x 103/µL and C-reactive pro-
tein of 20.0 mg/dL. The serum level
of liver transaminase was normal, and
both Wassermann reaction and anti-
HIV antibody tests were negative.
Pharyngolaryngitis and pneumonia
was diagnosed in the patient. Because
of severe dyspnea, intubation was per-
formed, which caused sudden and
unexpected exacerbation of the condi-
tion. Severe cyanosis subsequently
developed. Extubation was immedi-
ately performed, and a thick white
material was found to be filling the
lumen of the endotracheal tube.
Reintubation was performed, and dys-
pnea subsided. The patient was hospi-
talized in the intensive-care unit.
Sulbactam sodium/ampicillin sodium
(6 g per day) was intravenously
administered for 4 days; however, the
symptoms were not much improved.
The symptoms were most consistent
with those of diphtheria. Therefore,
the patient was subsequently placedEmerging Infectious Diseases • Vol. 9, No. 6, June 2003 753
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on erythromycin (1.0 g/day) and
quickly responded to this treatment
without administration of diphtheria
antiserum. Erythromycin was intra-
venously administered at 1 g per day
for 9 days, then orally administered at
1,200 mg per day for the next 14 days.
Throughout the hospitalization, no
complication occurred, and no abnor-
malities were noted in the electrocar-
diograms or in the patient’s neurolog-
ic status. The patient was discharged
uneventfully, and no serious sequelae
were noted for 20 months. History of
immunization for diphtheria was not
known.
After the hospitalization for this
acute illness, a laboratory report
showed that C. ulcerans was cultured
from the thick white coat of the throat.
No other bacteria were found. The
National Institute of Infectious
Diseases in Tokyo later confirmed
identification of the bacteria. By using
Elek’s test, Vero cell toxicity, and
polymerase chain reaction for toxi-
gene, this strain of C. ulcerans was
proven to produce diphtheria toxin
identical to C. diphtheriae (2–4).
Although administering appropriate
antibiotics as well as antitoxin is a
standard of care for patients with
diphtheria, antitoxin was not given to
this patient because of her rapid
response to the erythromycin therapy.
C. ulcerans infections in humans
occur after drinking unpasteurized
milk or coming in contact with dairy
animals or their waste (5,6). However,
person-to-person transmission of C.
ulcerans has not been reported, and in
some cases, the route of transmission
is not clear (7). Recently, C. ulcerans-
producing diphtheria toxin was isolat-
ed in the United Kingdom from cats
with nasal discharge (8). 
Our patient did not have direct
contact with dairy livestock or unpas-
teurized dairy products; however,
more than 10 dairy farms are scattered
around her home. Moreover, she kept
nearly 20 cats in her house and had
been scratched by a stray cat a week
before illness developed. This stray
cat, which had rhinorrhea and sneez-
ing, had wandered into her house. The
stray cat died before the patient
became ill, and no further investiga-
tion could be made. Stray cats might
well be one of the possible carriers of
C. ulcerans and might have transmit-
ted the bacteria to this patient. To our
knowledge, a case of human infection
caused by C. ulcerans has never been
reported in Japan. On the basis of cur-
rent experience, this bacterium does
exist in Japan and can potentially
cause a serious diphtheria-like illness
in humans. 
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Salmonella in Birds
Migrating through
Sweden 
To the Editor: To determine how
common  Salmonella infection is in
the migrating wild bird population,
we considered the biology of the bac-
terium and that of its avian hosts.
Previous studies have attempted to
determine in which stages wild birds
become infected, how infections are
acquired, and how this information
should be translated into epidemio-
logic risk assessments for human and
animal health. For instance, most pub-
lished studies originate from small
epizootics and are of either dead birds
at feeding stations (1) or infected
birds in or around barns where the
livestock has Salmonella infection
(2). This bias has important conse-
quences, as the natural prevalence of
Salmonella in the non-epizootic situa-
tion likely is overestimated. Finding
infected birds close to a barn with
infected cattle does not prove that
transmission occurred from the birds
to the animals. In addition, an epizoot-
ic at a feeding station does not prove
that  Salmonella normally occurs in
the inflicted bird species, as the birds
could have became infected through
proximity to the infected animals, or
in the case of the bird feeder, through
feed contaminated from an unknown
source. We need baseline surveillance
data on the prevalence of Salmonella
in non-epizootic situations, in healthy
bird communities and in different